China Medical System Holdings Limited (0867.HK)
HKD 7.36
(-0.67%)
HKD 7.36
(-0.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.5 Billion | 3.55 Billion | 2.49 Billion | 2.69 Billion | 2.55 Billion | 1.75 Billion |
| Net Income | 2.87 Billion | 3.76 Billion | 3.45 Billion | 2.81 Billion | 2.48 Billion | 2 Billion |
| Depreciation & Amortization | 229.56 Million | 227.22 Million | 219.82 Million | 208.31 Million | 204.05 Million | 198.99 Million |
| Deferred income taxes | -467.35 Million | -489.19 Million | -548.12 Million | - | - | - |
| Stock-based compensation | -35.87 Million | 18.71 Million | 17.15 Million | - | - | - |
| Change in working capital | 2.97 Million | 90.07 Million | -596.07 Million | 88.38 Million | 156.22 Million | -377.32 Million |
| Other non-cash items | -100.22 Million | -56.42 Million | -55.51 Million | -420.75 Million | -292.85 Million | -73.47 Million |
| Investing Cash Flow | -442.27 Million | -1.17 Billion | -1.51 Billion | -353.82 Million | -309.38 Million | -239.68 Million |
| Investments in PPE | -317.96 Million | -524.92 Million | -184.84 Million | -341.42 Million | -340.47 Million | -61.97 Million |
| Acquisitions | -123.61 Million | -298.82 Million | -563.9 Million | - | -16.07 Million | - |
| Investment purchases | -378.01 Million | -459.25 Million | -868.53 Million | -156.92 Million | -42.51 Million | -230.95 Million |
| Sales/Maturities of investments | 20.34 Million | 3.02 Million | -61.28 Million | - | -211.91 Million | - |
| Other Investing Activities | 356.97 Million | 101.77 Million | 159.04 Million | 144.52 Million | 301.58 Million | 53.23 Million |
| Financing Cash Flow | -2.12 Billion | -1.39 Billion | -258.39 Million | -1.03 Billion | -1.69 Billion | -1.55 Billion |
| Debt repayment | -1.78 Billion | -1.42 Billion | -10 Thousand | -696.93 Million | -801.59 Million | -717.94 Million |
| Dividends payments | -1.36 Billion | -1.27 Billion | -1.15 Billion | -834.12 Million | -822.75 Million | -728.51 Million |
| Common Stock Repurchased | - | -48.38 Million | -151.51 Million | -86.96 Million | - | -53.02 Million |
| Common Stock Issuance | - | 1.32 Billion | -51.81 Million | 593.28 Million | - | -45.02 Million |
| Other Financing Activities | -117.3 Million | 32.09 Million | 1.09 Billion | -9.81 Million | -70.79 Million | -9.8 Million |
| Accounts receivables | 410.55 Million | 185.5 Million | -451.33 Million | -157.67 Million | 166.26 Million | -262.86 Million |
| Accounts payables | -410.55 Million | - | - | - | - | - |
| Inventory | -235.76 Million | 8.15 Million | -90.86 Million | 25.84 Million | 24.65 Million | -51.26 Million |
| Other working capital | 238.73 Million | -103.58 Million | -53.87 Million | 220.21 Million | -34.7 Million | -63.19 Million |
| Cash at beginning of period | 4.37 Billion | 3.38 Billion | 2.66 Billion | 1.36 Billion | 815.08 Million | 855.62 Million |
| Cash at end of period | 4.31 Billion | 4.37 Billion | 3.38 Billion | 2.66 Billion | 1.36 Billion | 815.08 Million |
| Capital Expenditure | -317.96 Million | -524.92 Million | -184.84 Million | -341.42 Million | -340.47 Million | -61.97 Million |
| Effect of forex changes on cash | -871 Thousand | 15.51 Million | 1.37 Million | -232 Thousand | -669 Thousand | -1.11 Million |
| Net cash flow / Change in cash | -65.31 Million | 990.63 Million | 717.31 Million | 1.3 Billion | 549.92 Million | -40.54 Million |
| Free Cash Flow | 2.18 Billion | 3.02 Billion | 2.3 Billion | 2.35 Billion | 2.21 Billion | 1.69 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 455.21 Million | 455.21 Million | 2.87 Billion | 239.94 Million | 239.94 Million | 960.52 Million |
| Depreciation & Amortization | 57.03 Million | 57.03 Million | 229.56 Million | 74.73 Million | 63.01 Million | 51.77 Million |
| Deferred income taxes | - | - | -467.35 Million | - | - | - |
| Stock-based compensation | - | - | -35.87 Million | -17.93 Million | -17.93 Million | - |
| Change in working capital | - | - | 2.97 Million | 47.34 Million | 47.34 Million | - |
| Other non-cash items | -75.81 Million | -75.81 Million | -100.22 Million | 161.95 Million | 173.67 Million | -266.91 Million |
| Investing Cash Flow | -316.85 Million | -316.85 Million | -442.27 Million | -103.09 Million | -103.09 Million | -118.04 Million |
| Investments in PPE | -2.16 Million | -2.16 Million | -317.96 Million | -8.98 Million | -8.98 Million | -4.76 Million |
| Acquisitions | - | - | -123.61 Million | 58.15 Million | 58.15 Million | -58.15 Million |
| Investment purchases | - | - | -378.01 Million | - | - | - |
| Sales/Maturities of investments | - | - | 20.34 Million | - | - | - |
| Other Investing Activities | -314.69 Million | -314.69 Million | 356.97 Million | -152.26 Million | -152.26 Million | -55.13 Million |
| Financing Cash Flow | -316.96 Million | -316.96 Million | -2.12 Billion | -459.8 Million | -459.8 Million | -602.7 Million |
| Debt repayment | - | - | -1.78 Billion | - | - | - |
| Dividends payments | -95.99 Million | -95.99 Million | -1.36 Billion | -384.22 Million | -384.22 Million | -295.95 Million |
| Common Stock Repurchased | -119.19 Million | -119.19 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -101.76 Million | -101.76 Million | -117.3 Million | -75.57 Million | -75.57 Million | -306.75 Million |
| Accounts receivables | - | - | 410.55 Million | 205.27 Million | 205.27 Million | - |
| Accounts payables | - | - | -410.55 Million | - | - | - |
| Inventory | - | - | -235.76 Million | -117.88 Million | -117.88 Million | - |
| Other working capital | - | - | 238.73 Million | -40.04 Million | -40.04 Million | - |
| Cash at beginning of period | - | - | 4.37 Billion | - | - | - |
| Cash at end of period | -198.34 Million | -198.34 Million | 4.31 Billion | -70.15 Million | -70.15 Million | 37.49 Million |
| Capital Expenditure | -2.16 Million | -2.16 Million | -317.96 Million | -8.98 Million | -8.98 Million | -4.76 Million |
| Effect of forex changes on cash | -955.5 Thousand | -955.5 Thousand | -871 Thousand | -13.29 Million | -13.29 Million | 12.86 Million |
| Net cash flow / Change in cash | -198.34 Million | -198.34 Million | -65.31 Million | -70.15 Million | -70.15 Million | 37.49 Million |
| Free Cash Flow | 434.26 Million | 434.26 Million | 2.18 Billion | 497.05 Million | 497.05 Million | 740.62 Million |
MCRI
9364
OMV
GH
SLOFF
3839